Leveraging single-cell ATAC-seq data to gain insights into the cell-type selective component of the human pancreatic islet regulome

ATAC-seq is essential for profiling chromatin accessibility and characterizing the transcriptional regulatory landscape. However, the recent shift towards the study of heterogeneous cell populations poses a challenge for bulk ATAC-seq. Thus, single-cell ATAC-seq has emerged as a response to the limi...

ver descrição completa

Detalhes bibliográficos
Autor: Castillo Bonilla, Andrés
Formato: tesis de maestría
Fecha de publicación:2021
País:España
Recursos:Universitat Oberta de Catalunya (UOC)
Repositorio:O2, repositorio institucional de la UOC
OAI Identifier:oai:openaccess.uoc.edu:10609/134326
Acesso em linha:http://hdl.handle.net/10609/134326
Access Level:acceso abierto
Palavra-chave:human pancreatic islet
genome regulation
genetic
illot pancreàtic humà
regulació genòmica
genètica
islote pancreático humano
regulación genómica
genética
Pancreas -- TFM
Pàncrees -- TFM
Páncreas -- TFM
Descrição
Resumo:ATAC-seq is essential for profiling chromatin accessibility and characterizing the transcriptional regulatory landscape. However, the recent shift towards the study of heterogeneous cell populations poses a challenge for bulk ATAC-seq. Thus, single-cell ATAC-seq has emerged as a response to the limitations of bulk ATACseq when studying cellular heterogeneity. We aim to to characterize the cell-typeselective component of enhancers using scATAC-seq data. To achieve this purpose, we a) annotate regulome signatures across cell-type selective open chromatin regions, b) estimate TF motif enrichment among cell-type selective enhancers, c) detect accessible cell-type selective enhancers that show robust TF binding and d) identify T2D-associated SNPs affecting TF binding across celltype selective enhancers. Motif enrichment analysis presented well-defined groups of TF motifs enriched across islet cell-type selective enhancers. TF motif occurrences across cell-type selective enhancers showed that enhancers bound by a given TF was consistent with the cell-type selective clustering observed in the TF motif enrichment analysis. Finally, the integration of TF-binding characterizing islet cell-type enhancers with fine-mapped T2D genetic variants allowed us to propose the most likely molecular mechanism underlying a few T2D risk loci.